Dermata Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Dermata Therapeutics, Inc. has filed 358 SEC EDGAR filings since 02 Apr 2021

SEC filing history

Showing 26-50 of 358 matching filings.

Per page
25
Current page
2
EFFECT File 333-292885

EFFECT filing

Filing date
29 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-292885

424B3

Filing date
29 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-292885

UPLOAD filing

Filing date
27 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-268383

424B5

Filing date
27 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92822

SCHEDULE 13D/A filing

Filing date
08 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-569228

D filing

Filing date
07 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2026
Reporting date
02 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92822

SCHEDULE 13G filing

Filing date
02 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92822

SCHEDULE 13G filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Dec 2025
Reporting date
23 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Dec 2025
Reporting date
23 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .